Filing Flows › NeuroPace (NPCE) › Q1 2026 › vs Q4 2025
NeuroPace (NPCE) Q1 2026 vs Q4 2025 (quarter over quarter)
NeuroPace's revenue fell $4.5M (-17%) from $26.6M in Q4 2025 to $22.1M in Q1 2026.
NeuroPace, Q1 2026: revenue $22.1M (-2% year over year), operating margin -25.2%, net loss $6.7M, operating cash flow −$5.9M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $22.1M | $26.6M | −$4.5M | -17% |
| Net loss | $6.7M | $2.7M | $4.0M | +145% |
| Costs & expenses | $28.8M | $29.3M | −$560K | -2% |
| Operating costs | $27.6M | $28.4M | −$719K | -3% |
| Interest & other, net | $1.1M | $962K | $159K | +17% |
| Cost of revenue | $4.0M | $6.0M | −$2.0M | -33% |
| Research & development | $7.2M | $7.0M | $162K | +2% |
| Sales & marketing | $11.6M | $10.9M | $647K | +6% |
| General & admin | $4.8M | $4.4M | $462K | +11% |
| Operating cash sources | $8.2M | $2.2M | $6.1M | +278% |
| Depreciation | $60K | $80K | −$20K | -25% |
| Share-based compensation | $2.3M | $2.6M | −$329K | -13% |
| Cash used in operations | $5.9M | −$506K | $6.4M | — |
| Net loss absorbed | $6.7M | $2.7M | $4.0M | +145% |
| Working capital & other | $1.5M | −$548K | $2.1M | — |
Questions
How much did NeuroPace's revenue grow quarter over quarter in Q1 2026?
NeuroPace's revenue fell $4.5M (-17%) from $26.6M in Q4 2025 to $22.1M in Q1 2026.